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potential involvement in mild hyperhomocysteinemia
Mildly elevated plasma homocysteine has been and premature vascular disease as suggested by Boersshown to be associated with an elevated risk for
et al. (9) and Clarke et al. (10), who reported decreasedcardiovascular disease. In this study, we analyzed
CBS activities in ®broblasts of hyperhomocysteinemicthe frequency of a common 844ins68 insertion vari-
vascular disease patients.ant in the cystathionine b-synthase gene (CBS) in
In our study on the involvement of heterozygositypatients with arterial occlusive disease and in con-
trols and assessed the association between the in- for CBS de®ciency in cardiovascular disease (11), we
sertion variant and plasma homocysteine concen- also encountered the 844ins68 mutation in the cod-
trations. The insertion variant was equally distrib- ing region of exon 8 of the CBS gene, an insertion
uted between both study groups. Furthermore, the variant which exactly duplicates the splice junction
presence of this insertion variant, either in the het- site of exon 8 and which was previously described
erozygous or the homozygous state, is not associ- by Sebastio et al. (7) as a possible pathogenic muta-
ated with hyperhomocysteinemia. We therefore tion in an Italian homocystinuria patient. Recently,conclude that this common 844ins68 variant is a
the same group (12) and another one (13) providedneutral insertion variant. q 1997 Academic Press
evidence that this 68-bp insertion is a common inser-Key Words: cystathionine b-synthase; insertion
tion variant in the CBS gene and is most likelyvariant; homocysteine; vascular disease; alternative
skipped by alternative splicing of the nuclear CBSsplicing; genetic marker.
mRNA. Unlike Tsai et al. (13), Sperandeo et al. (12)
did not measure plasma homocysteine, so the effect
Mild hyperhomocysteinemia has been recognized as of this insertion variant with data on plasma homo-
an independent and graded risk factor for arterioscle- cysteine could not be studied. Furthermore, they
rosis (1) and thrombosis (2) and may result from envi- speculated that this variant, in combination with
ronmental and genetic factors. The main regulating homozygosity for the 677C r T mutation in the
enzymes in homocysteine metabolism are cystathio- MTHFR gene, might further hamper homocysteine
nine b-synthase (CBS; EC 4.2.1.22) and methylenetet- metabolism. In this report, we present our results
rahydrofolate reductase (MTHFR). CBS, which is a on the prevalence of this common insertion variant
homotetrameric enzyme, catalyzes the ®rst reaction in in patients with premature arterial occlusive disease
the transsulfuration pathway, in which homocysteine and controls and provide data on its effect on homo-
and serine are condensed to cystathionine. Since the cysteine metabolism.
cloning and characterization of the human CBS cDNA
MATERIALS AND METHODS(3), many efforts have been made to elucidate muta-
tions causing severe hyperhomocysteinemia due to
SubjectsCBS de®ciency, which resulted in the identi®cation of
20 mutations in the CBS cDNA (4±8). The interest We analyzed 60 patients with different forms of
arterial occlusive disease and 107 controls recruitedin the molecular basis of CBS is enhanced due to its
23
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TABLE 1 the Hardy±Weinberg equation. In our study, there
Genotype Distribution of the 844 ins68 Mutation was no substantial difference in carrier status of the
in Vascular Disease Patients and in Controls insertion between patients and controls (x2  1.86,
P  NS).
Vascular disease Mild aberrations in the transsulfuration pathwaypatients Controls
are often found to be associated only with elevatedGenotype (n  60) (n  107)
plasma homocysteine concentrations after a stan-
NN 50 (83.3%) 89 (83.2%) dardized methionine loading. We therefore com-
NI 10 (16.7%) 15 (14.0%) pared not only fasting but also post-load plasma ho-
II 0 (0%) 3 (2.8%) mocysteine concentrations and the increase in
plasma homocysteine upon methionine loadingNote. x2  1.86; P  NS; N, normal sequence; I, insertion.
within the three different genotypes of combined
groups of patients and controls (Table 2). The indi-
from a general practice; both groups have been de- viduals with the insertion on both alleles did not
scribed extensively before (11,14). All individuals have increased homocysteine concentrations. Their
agreed to participate in this study. plasma homocysteine levels were even lower, al-
though not signi®cant, compared with the other ge-DNA Ampli®cation and Detection of Insertion
notypes, both in fasting state and after a methionine
DNA was extracted from peripheral blood lympho- loading test. Heterozygosity for the insertion variant
cytes by a standard method (15). Approximately 100 also did not in¯uence plasma homocysteine concen-
ng of DNA was ampli®ed by PCR, using 50 ng for- trations. Because homozygosity for the 677C r T
ward primer (5*-CTGCCTTGAGCCCTGAAGCC-3 *; transition in the MTHFR gene, which has been
intronic), 50 ng reverse primer (5*-CGTCCTGTC- shown to be associated with elevated plasma homo-
CAGCACCGT-3 *; cDNA 937±954), 200 mM each cysteine concentrations (11), could mask a possible
dNTP, and 1 unit Taq polymerase (Life Technolo- effect of the 844ins68 variant on plasma homocys-
gies, Breda, the Netherlands) in a standard PCR teine levels, we also assessed the homocysteine con-
buffer. After an initial denaturation at 957C for 3 centrations in individuals after excluding those sub-
min, ampli®cation was performed in 35 cycles (927C/ jects homozygous for the 677C r T polymorphism
1 min, 527C/1 min, 727C/1 min), followed by a ®nal in the MTHFR gene. Again, we observed that the
extension at 727C for 7 min. The PCR products were insertion variant does not affect plasma homocys-
subjected to agarose gel electrophoresis, ethidium teine concentrations (data not shown).
bromide staining, and UV illumination for detection The 844ins68 insertion variant was previously de-
of the 844ins68 insertion variant. The wild-type al- scribed as a possible pathogenic mutation in an Ital-
lele yielded a fragment of 159 bp, whereas ampli®- ian homocystinuria patient and was postulated to
cation of the inserted allele generated a fragment of introduce a premature translation termination co-
227 bp. don, which would result in a truncated CBS mono-
Statistics
TABLE 2
Differences in allele frequencies and genotype dis- Relationship between Insertion and Plasma
tribution between vascular disease patients and con- Homocysteine Concentrations
trols were assessed by x2 analysis. A P value less
Genotypethan 0.05 was considered statistically signi®cant.
NN NI IIRESULTS AND DISCUSSION
Fasting HCy 13.2 { 4.8 12.7 { 2.8 10.2 { 2.8The allele frequency of this insertion was 0.083 (mmol/L) (n  137) (n  25) (n  3)
among vascular disease patients versus 0.098 among Post-load HCy 41.7 { 16.2 36.4 { 10.1 34.0 { 12.4
(mmol/L) (n  137) (n  24) (n  3)controls (x2  0.063; P  NS), which is in line with
Increase 28.4 { 13.5 23.7 { 9.1 23.9 { 11.3the observations by Tsai et al. (13), who found an
(mmol/L) (n  136) (n  24) (n  3)allele frequency of 0.085 versus 0.058 in coronary
artery disease patients and controls, respectively. Note. Results are expressed as mean { SD. Increase is post-
The genotype distribution of this insertion among load homocysteine minus fasting homocysteine concentration. N,
normal sequence; I, insertion.patients and controls (Table 1) is in agreement with
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